FDA Covid-19 Response
FDA is working with U.S. Government partners, including CDC, and international partners to address the pandemic.
Featured Topics

New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.

Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.

Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Jan 16
Potential Foreign Object Recall Lake Champlain Chocolates Issues Voluntary Recall on Selected Milk Chocolate Products
Food & Beverages
Jan 11
Boston Scientific Announces LOTUS Edge™ Aortic Valve System Voluntary Recall and Product Discontinuation
Medical Devices
Jan 11
Midwestern Pet Foods Voluntarily Expands Recall of Pet Food for Aflatoxin Health Risk
Animal & Veterinary, Food & Beverages
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS

Accelerating the Adoption of Advanced Manufacturing Technologies to Strengthen Our Public Health Infrastructure
FDA and industry have to accelerate the adoption of advanced manufacturing technologies to strengthen the nation’s public health infrastructure.

Pandemic Response, Pandemic Preparation
Pandemic Recovery and Preparedness Plan initiative strengthens on-going COVID-19 pandemic response and our resiliency for future public health emergencies.

Better Data for a Better Understanding of the Use and Safety Profile of Cannabidiol (CBD) Products
Real-world data on CBD use and safety has a crucial role to fill in the current gaps in our understanding.
Recently Published Guidances
Jan 15
Investigational COVID-19 Convalescent Plasma
Biologics
Jan 15
Protecting Participants in Bioequivalence Studies for Abbreviated New Drug Applications During the COVID-19 Public Health Emergency
Drugs
Jan 14
Coagulation Systems for Measurement of Viscoelastic Properties: Enforcement Policy During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency
Medical Devices